COLL - COLLEGIUM PHARMACEUTICAL, INC

QQQ $ 448.08 $ -0.84 (-0.19 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.96 $ -0.28 (-0.13 %)

Previous Close

$ 33.29

Open

$ 32.08

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 31.84 - $ 33.32

52 Week Range

$ 20.83 - $ 40.95

Volume

732,658

Average Volume

Market Cap

1.38B

Beta (5Y Monthly)

$ 0.94

PE Ratio (TTM)

$ 14.79

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-05-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	02-27-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-07-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	03-10-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-11-2016	06-30-2016	10-Q
33	05-11-2016	03-31-2016	10-Q
34	03-18-2016	12-31-2015	10-K
35	11-12-2015	09-30-2015	10-Q
36	08-12-2015	06-30-2015	10-Q
37	06-22-2015	03-31-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Collegium Announces $35M Accelerated Buyba...
05/13/2024 12:17:58

Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutical company committed to improving th...

Demystifying Collegium Pharmaceutical: Ins...
05/10/2024 14:01:05

Needham Downgrades Collegium Pharmaceutica...
05/10/2024 11:43:12

Needham analyst Serge Belanger downgrades Collegium Pharmaceutical (NASDAQ:COLL) from Buy to Hold.

Piper Sandler Downgrades Collegium Pharmac...
05/10/2024 09:25:57

Piper Sandler analyst David Amsellem downgrades Collegium Pharmaceutical (NASDAQ:COLL) from Overweight to Neutral and mainta...

Collegium Board Authorizes $35M Accelerate...
05/09/2024 21:13:43

Collegium Reaffirms FY24 Guidance For Prod...
05/09/2024 21:13:14

Collegium Pharmaceutical Q1 2024 Adj EPS $...
05/09/2024 20:46:50

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate...

Collegium Says Joe Ciaffoni Will Step Down...
05/09/2024 20:03:43

Collegium Announces Authorized Generic Agr...
04/29/2024 12:22:09

Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutical company committed to improving th...

Critical Insights From Collegium Pharmaceu...
04/11/2024 13:00:45

Needham Reiterates Buy on Collegium Pharma...
04/11/2024 09:58:07

Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $40 price target.

Truist Securities Maintains Buy on Collegi...
02/26/2024 13:20:03

Truist Securities analyst Les Sulewski maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price targ...

Where Collegium Pharmaceutical Stands With...
02/23/2024 19:01:01

Collegium Reaffirms Its Full-year 2024 Gui...
02/22/2024 22:03:04

Recap: Collegium Pharmaceutical Q4 Earnings
02/22/2024 21:35:12

Collegium Pharmaceutical Q4 2023 Adj EPS $...
02/22/2024 21:32:23

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Analyst Expectations For Collegium Pharmac...
02/02/2024 13:00:38

Needham Reiterates Buy on Collegium Pharma...
02/02/2024 11:57:01

Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $40 price target.

Needham Maintains Buy on Collegium Pharmac...
01/04/2024 17:54:46

Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from ...